Universal Scientific Industrial (Shanghai) (601231) Q1 2026 earnings summary

Executive summary

• Revenue for Q1 2026 was RMB 13.35 billion, down 2.19% year-over-year.

• Net profit attributable to shareholders rose 24.57% year-over-year to RMB 417.26 million.

• Excluding non-recurring items, net profit increased 45.69% year-over-year.

• Cash flow from operations decreased 32.30% year-over-year due to changes in customer orders and early material procurement.

Financial highlights

• Operating profit for Q1 2026 was RMB 484.52 million, up from RMB 393.23 million a year ago.

• Basic and diluted EPS were RMB 0.18, up 20% year-over-year.

• Total assets at quarter-end were RMB 40.58 billion, up 0.24% from year-end 2025.

• Shareholders’ equity increased 11.59% from year-end 2025.

Outlook and guidance

• Q2 2026 revenue is expected to grow by a mid-single digit percentage year-over-year.

• Q2 operating margin is projected to improve and return to 2024 levels, contingent on stable global conditions.